Clinical Trial

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

Name: Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer — clinical trial record (NCT07125924)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of intravesical hyaluronic acid (HA) instillation therapy for the prevention of radiation-induced cystitis in patients undergoing radiotherapy for bladder cancer.

Trial Details

NCT Number	NCT07125924
Lead Sponsor	National Cancer Center, Korea
Conditions	Bladder Cancer, Radiation Cystitis
Enrollment	54 participants
Start Date	2025-08-22
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-15